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Abstract
Background—In vitro growth techniques for intestinal crypts and single intestinal stem cells
have been recently described, but several questions of translational importance remain
unaddressed. The purpose of this study was to: first, evaluate if intestinal crypts reproducibly
expand in vitro; second, determine the impact of age and region of intestine on crypt growth in
vitro; and third, determine the effects of cryopreservation on crypt growth in vitro.
Methods and Materials—Crypts were harvested, from 5 cm of proximal, middle and distal
small intestine of C57BL/6J mice aged 4wk, 6-8wk, 12-14wk, and 18-20wk (n = 4-6 animals), and
cultured. For each region, we determined the efficiency of crypts forming enterospheres (Day 1),
and progressing to enteroids (Day 7). Subsequently, enteroids were passaged and cryopreserved to
determine if growth was changed by these manipulations.
Results—43-99% of intestinal crypts formed enterospheres, with higher efficiency in proximal
small intestine and in younger mice. 25-64% of enterospheres progressed to budding enteroids
within 7 days. In vitro expansion was greater in proximal enteroids. This expansion continued in a
logarithmic fashion, with ~97% replating efficiency of isolated enteroid crypt buds. Following
cryopreservation, ~90% of enteroids recovered normal proliferative capacity.
Conclusions—Intestinal crypt culture is efficient and significantly expands intestinal tissue in a
reproducible manner. Regional and age growth differences may reflect distinct stem cell
characteristics or differences in support cells. The ability to culture and expand intestinal tissue in
vitro provides a potential translational approach toward understanding and treating patients with
short bowel syndrome.
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Short bowel syndrome (SBS) occurs when loss of intestinal length results in the inability of
the bowel to absorb the nutrients and/or fluids necessary for normal physiology and
growth[1]. Current therapy for SBS supports fluid and nutritional needs in the form of
parenteral nutrition (PN) that is gradually weaned with concomitant increases in enteral
nutrition over the period of time required for the remaining intestine to adapt. When
adequate adaptation does not occur within 2-3 years following intestinal injury or loss, a
lifetime requirement for PN is common. Current literature indicates that the preserved region
of bowel affects outcomes, as patients without their distal ileum and proximal colon require
longer periods of time to adapt and wean off of PN. These patients also have a higher
incidence of chronic intestinal failure compared to patients with similar losses of proximal
jejunum [2]. Supporting this finding, several studies demonstrate a greater ability of the
ileum to undergo hyperplasia and adaptive response following resection of the proximal
bowel than the converse [3]. This regional disparity in adaptation may be due to differences
in the intestinal stem cells that continuously regenerate the epithelium.
Ideally, the use of tissue-engineered small intestine (TESI) from ex-vivo expansion of a
patient's own tissue offers therapeutic potential for SBS by either increasing overall
absorptive surface area or specifically restoring the physiological loss of regionalized bowel.
TESI investigators have demonstrated proof of principle by intestinal formation in large
animal models, and abrogation of nutritional deficits in a small animal model of SBS [4-6].
Despite this progress, there remain limitations, namely: (a) the reliance on neonatal donor
tissue; and (b) the inability to expand the donor tissue [7].
Early ex vivo/ in vitro culture methods of the small bowel are marked by numerous
drawbacks including lack of normal morphology, degradation with time, and lack of
appropriate differentiation [8]. However more recently, long-term culture conditions, which
differentiate and recapitulate normal crypt-villus architecture have been devised initially for
mouse tissue [9, 10] and subsequently for human tissue [9, 11-13]. These studies also
suggest an expansion of starting tissue [9-13].
To date, despite these advances in culture of the small intestine there has been no systematic
and quantitative assessment of the capacity to expand tissue either in vitro or in vivo as
required for TESI to be clinically practical [7]. In fact, with current methods there is a
substantial loss of tissue, limiting the current usefulness for therapy. Thus, with recent
advances in methods for intestinal epithelial culture, we sought to answer three questions:
(1) Does age impact the ability to efficiently culture crypts across adulthood; (2) Does the
region of origin impact the ability to efficiently culture crypts; (3) Can we expand and store
isolated intestinal crypts with current culture techniques?
Materials and Methods
Experimental Design
To investigate the influence of a) age and b) region, on crypt culture in a quantitative
fashion, we separated the small intestine into three regions termed proximal, middle, and
distal. We further categorized mice by age to cover weanlings to adulthood. We then
cultured crypts isolated from these categories and monitored their progress. To evaluate the
ability of crypts to expand in vitro we examined the number of new crypt domains and
maintenance of budding over time. To evaluate the ability to store expanded crypts for later
usage, we examined percent of enteroids revived after freezing and maintenance of crypt
budding after freeze-thaw.
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All animal procedures were approved by the Institutional Animal Care and Use Committee
at UNC and CCHMC. Male, C57BL/6J mice were obtained from Jackson Laboratories (Bar
Harbor, ME) at ages 4, 6-8, 12-14, and 18-20 weeks of age (n= 4, 6, 4, 6). They were
subsequently housed four per cage on a 12 hr light dark cycle.
Tissue Harvest for Intestinal Crypts
After carbon dioxide euthanasia, the small intestine was removed and flushed with cold
phosphate buffered saline (PBS), the first 2-3 cm adjacent to the pylorus and the distal 2-3
cm just proximal to the ileocecal valve were discarded. The 5 cm adjacent to these regions
were termed “proximal” and “distal” respectively. The “middle” region was defined as the 5
cm at the midpoint of the remaining intestine. Each segment, proximal (P), middle (M), or
distal (D), was then opened longitudinally and cut into 5 mm pieces. Pieces were transferred
to 3mM EDTA in PBS and rocked for 30 min at 4°C. After manual shaking for 30 sec, the
tissue was moved to fresh cold PBS and shaken for 3-5 min. Sorbitol (2%) (SIGMA, St.
Louis, MO) was then added 1:1 to the solution and the crypts filtered through a 70 μm filter.
The flow-through was then checked for crypt density and an appropriate volume pelleted at
150xg for 10 min at 4°C.
Crypt Culture and Quantification
The pelleted crypts were resuspended in growth factor reduced Matrigel (BD Bioscience)
supplemented with EGF (50ng/mL), Noggin (100ng/mL), R-spondin (500ng/mL), wnt3a
(5ng/mL), and Y27632 (10μM) (R&D Systems, Minneapolis, MN; Invitrogen, Carlsbad,
CA). [All concentrations are for total well volume.] With the exception of wnt3a, these
conditions are those described by Sato et al [14]. A mean of 29 crypts in 10μL of Matrigel
were then plated in 6 experimental replicates per region on 48 well plates. Each was then
overlaid with DMEM/F12 (GIBCO, Carlsbad, CA) supplemented with Hepes (10mM), N2
(1:100), B27 (1:50), L-glutamine (1:100), and penicillin/streptomycin (1:100) (Invitrogen).
The final number of crypts plated was counted per well. Each well was quantified on day 1
of culture for enterosphere (Fig. 1C) formation. At Day 4, media was changed and EGF,
Noggin, R-spondin, and wnt3a at original concentrations were added to each well. At Day 7,
each well was counted for enteroid formation (Fig. 1D). Among formed enteroids, lateral
crypt buds were counted across a minimum of two wells and ten enteroids per region and
mouse. Enterosphere and enteroid efficiencies were defined as a percentage of enterospheres
or enteroids, respectively, divided by the number of crypts initially plated.
Maintenance of Enteroids over Time
To assess the performance of cultures over time and promote continued growth, enteroids
were mechanically dissociated via passage through a 30 gauge needle after 7 days in culture.
Enteroid units were then resuspended in PBS and pelleted at 150xg. Supernatant of PBS and
Matrigel was discarded and enteroid units resuspended in fresh Matrigel according to initial
crypt culture conditions. This was repeated every 7 days for the life of the culture. For
quantification, only passages resulting in single crypt buds were utilized. Number of crypt
buds replated was counted on day 1 after passaging. The number of enteroids formed from
these buds was then counted on day 7 prior to the next passage. Quantification of the 1st and
2nd passages (21 days in culture) was performed in 4 experimental replicates per mouse.
Effect of Freeze-Thaw
Enteroids were cultured as above and counted then passaged at 7 days. After an additional 3
days in culture, enteroids were removed from Matrigel by aspirating media off each well,
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adding 500uL of PBS, and repeatedly pipetting to breakup Matrigel. The contents of each
well were removed and 5mL of PBS added then centrifuged for 10 min at 150xg. The
supernatant was discarded and enteroids were then resuspended in freezing media (advanced
DMEM/F12 with 10%DMSO and 10% FBS). Enteroids were then frozen in an isopropyl
alcohol freezing container (Nalgene, Rochester, NY). After freezing, vials were transferred
to liquid N2 storage. After 7 days in storage, enteroids were quickly thawed then centrifuged
for 10 min at 150xg to remove the freezing media. Enteroids were resuspended in Matrigel
with growth factors and overlaid with media as previously described. At 1 day in culture,
enteroids were counted for initial plating density per well. After 3 days in culture, enteroids
were assessed for viability based on morphology. Enteroids were then passaged and plated
at a mean density of 25 buds/well. These buds were then cultured an additional 7 days
before crypt budding was assessed as previously described.
Statistical Analysis
To analyze progression of: crypts to enterospheres, enterospheres to enteroids, and
enterospheres to enteroids by age and region, three repeated measures logistic regression
analyses were performed. The response variable was yes/no on: 1) whether a crypt survived
to an enterosphere at day 1, (2) whether a crypt progressed to an enteroid at day 7, and (3)
whether an enterosphere at day 1 progressed to an enteroid at day 7. For each analysis, the
site factor (P, M, and D) was nested within the time factors (weeks 4, 8, 14, and 20). Since
measurements within the same mouse at the same site were expected to have similarly
correlated measurements a compound symmetric correlation matrix was used. An overall
test of interaction between site and time was performed and if it proved statistically
significant then subgroup comparisons of interest were made. Additionally, to predict bud
counts a Poisson regression was performed in an otherwise similar manner to
aforementioned models. P-values less than 0.05 were considered statistically significant.
Analyses were performed using SAS Version 9.2 (SAS Institute, Cary NC).
To analyze the maintenance of efficiency over time and crypt budding over time in culture,
as a single region and time were utilized, 1-way ANOVA with Bonferroni posttest
corrections for multiple comparisons was performed. P-values less than 0.05 were
considered significant. Analyses were performed in GraphPad Prism 5 (LaJolla, CA).
RESULTS
Behavior of Crypts in Culture
As shown in Fig. 1A-B, following plating, crypts rapidly move from normal crypt
architecture to formation of spheroid structures. In accordance with the recommendations
from the Intestinal Stem Cell Consortium (ISCC http://iscc.coh.org), we have termed these
structures “enterospheres.” Over subsequent time in culture the enterospheres undergo
extensive budding to give rise to more complex structures termed “enteroids” (Fig. 1C). A
typical enteroid from the proximal intestine at 7 days in culture is shown in Fig. 1D. The
term “organoids” will be reserved for cultures also containing mesenchyme (ISCC http://
iscc.coh.org).
Efficiency of Enterosphere Formation
Tissue from all regions of the small intestine and from all ages studied formed enterospheres
with mean efficiencies ranging from 43-99% of crypts plated (Fig. 2A). Both age and region
demonstrated a significant effect on survival and significantly interacted with each other (p
< 0.02). As such, subgroup analyses were performed within age or region. Efficiency was
significantly greater in the proximal than the distal segment at 14 and 20 wks (p < 0.05). At
4 wks of age, there was a trend to greater efficiency in the proximal than the distal segment.
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At 8 wks of age, all segments formed enterospheres equally well. Within all regions, 20wk
crypts formed enterospheres less efficiently than 14 wk (p < 0.05). In the distal and middle
regions, 20 wks was also less efficient than 8 wk (p < 0.05).
Efficiency of Enteroid Formation
Tissue from all regions of the small intestine and ages studies formed enteroids with mean
efficiencies ranging from 25 – 64% of crypts plated (Fig. 2B). Significant interaction
persisted between age and region (p < 0.02). In contrast to enterosphere efficiency, enteroids
formed equally well between regions at 4, 8, and 14 wks. Only at 20 wks was the proximal
region more efficient than middle or distal regions at enteroid formation (p < 0.05).
However in examining animal age, within all regions 8wk crypts were more likely to form
enteroids than 14 or 20wk (p <0.05).
Progression from Enterosphere to Enteroid
We next calculated progression of enterospheres to enteroids to determine if low enteroid
efficiency was caused by failure of enterosphere formation or failure of progress once
initially formed. Progression occurred in 29 – 76% of enterospheres (Fig. 2C).
Enterospheres progressed equally well between regions at each age. However, 8 wks of age
progressed significantly better than 14 wks across all regions (p < 0.05). Within the
proximal crypts, 20 wks progressed significantly better than 14wks (p < 0.05).
Number of Crypt Buds per Enteroid
To assess regional and age influences on in vitro growth, the number of crypt buds per
enteroid was quantified as a surrogate for expansion of intestinal stem cells, as each bud is
capable of independently forming a new enteroid. No significant interaction was present
between age and region (p > 0.12); thus, main effects of age and region were compared. At 4
wks of age enteroids possessed significantly fewer buds than 8, 14, or 20 wks, which did not
differ from each other (p < 0.005 data not shown). As shown in Fig. 3, a strong regional
effect was present with number of crypt buds greatest proximally (7.2) and declining
through the middle (5.3) and distal (3.7) regions (p < 0.001).
Passaging of Enteroids to Determine Efficiency and Proliferation Over Time
Although we initially confirmed expansion of crypts, we further examined the potential to
expand crypts in vitro through passaging of enteroids to promote continued growth.
Enteroids passaged down to single crypt buds were replated. There was high efficiency (93 –
100%) of crypt buds progressing to new enteroids with passaging (Fig. 4). Additionally,
enteroids maintained their ability for continued expansion, as there is no significant
difference in the number of crypts buds formed per enteroid in reference to initially plated
crypts forming enteroids at day 7(data not shown).
Enteroid Efficiency Following Freeze-Thaw
Following thawing of enteroids, 90% ± 2 and 87%± 2 survival was observed for proximal
and distal enteroids respectively (n=4). In addition, enteroid morphology and crypt budding
was maintained as prior to freezing (data not shown).
Fold Expansion
The ability of crypts to be expanded for autotransplantation is one of the major goals of in
vitro culture; as such, fold expansion was calculated. As each crypt bud represents a new
crypt domain, fold expansion was calculated by multiplying enteroid efficiency at 7 days by
the mean number of crypt buds per enteroid. Pooled data for all ages showed that expansion
varied between 3.4 to 1.4 fold at 7 days from proximal to distal respectively (Fig. 5). If the
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single most proliferative age and region is examined, 8 wks of age in the proximal intestine,
expansion at 7 days is already 4 fold (Fig. 5). If we take this culture out to 28 days and 2
passages, each dissociated crypt bud will reform an enteroid with an average of 7 buds.
Thus, we will go from 4 crypts to 28 crypts after passage 1 (100% efficiency). These 28
enteroids will passage with 93% efficiency to form to 182 crypts. When passaged at 93%
efficiency, these 182 enteroids will represent 1183 new crypt axes at 28 days in culture. We
have continued this process with similar efficiency beyond 10 passages.
Discussion
While culture techniques to maintain ISC and intestinal crypts have been recently described,
several issues of translational importance had not been previously investigated. In this study,
we have demonstrated that: a) crypt culture is influenced by both the age and region of the
donor small intestine; b) crypts can be expanded in vitro; c) expanded crypts can be stored
for later usage.
On examination of the effects of age and region on crypt culture, overall there is good
progression across ages and regions examined. However, the proximal jejunum tended to
form enteroids more efficiently than the distal ileum. Interestingly, this regional effect may
be secondary to the ability of proximal crypts to initially form enterospheres more
efficiently, as once enterospheres are formed there is no significant difference in their
progression to enteroids. Likewise, 20wk adult crypts were less likely to form enterospheres,
but once formed enterospheres progressed well and in fact better than at 14 wks of age.
Assuming the behavior of mouse tissue predicts that of human tissue, this implies that
translational applications will not be limited to embryonic and fetal sources of intestine;
autotransplantation, even into adulthood, may be possible by expansion of the differentiated
stem cells present among crypts for all regions of the bowel.
In the initial report of crypt culture Sato et al. presented convincing evidence that enteroid
crypt buds represent new crypt-villus axes [14]. As such, enteroid budding may be akin to
expansion of the intestinal stem cell (ISC) compartment and formation of new crypts via
crypt fission [15]. On close examination of our data related to crypt budding, a marked
proximal (highest) to distal (lowest) gradient of bud number was observed. This implies that
the ISCs of the proximal intestine may be either more responsive to culture conditions
(which are high in wnt signals), or may possess intrinsic differences to ISCs of the distal
intestine. Alternatively the support cells at the crypt base may function differently in the
proximal intestine than in the distal intestine. Isografts with intact fetal intestine have
demonstrated maintenance of regional expression [16]; however, recent culture systems
have yet to examine whether this holds true in vitro. These differences in proximal-distal
crypt budding, suggest that the functional diversity of small intestine in vivo may be
maintained in vitro. This also underscores the potential ability of this robust culture system
to be used for asking questions of the crypt-villus axis and the signaling involved in normal
homeostasis and in disease states.
One of the most important findings of this paper is that under these culture conditions crypts
can be significantly expanded in vitro. As crypt buds represent new crypt-villus axes they
are also indicative of tissue expansion in vitro. If anything, this study underestimates crypts
potential for expansion by only counting lateral buds. Nonetheless, expansion at 7 days in
culture was observed for even the distal region, which exhibited the least efficiency of
enteroid formation. Furthermore, each enteroid, when dissociated to single crypt buds,
retains its proliferative capacity so with increased time in culture tissue will expand
logarithmically. Additionally, there is little loss of enteroids following cryopreservation and
enteroids maintain their proliferative capacity after thawing. These abilities to expand tissue
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in vitro, store it, and subsequently utilize it holds tremendous promise for future therapeutic
usage.
Gut tissue engineering has become increasingly sophisticated, with the ability for
anastomosis and abrogation of intestinal failure; however, as noted in Gupta et al. the ability
to expand this tissue to a clinical useful number has remained an important limitation [7].
The culture system reported here provides one method to expand epithelium in vitro prior to
tissue engineering applications. Additionally, enteroids may be stored for later usage e.g.
autologous transplantation. Lastly, the robust and reproducible nature of crypt culture
represents an in vitro system to begin examination of normal homeostasis, response of the
intestine to stress, and the potential for ISC dysregulation implicated in intestinal disease
and cancer.
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FIG. 1. Images demonstrating progression of crypts in culture
All panels are at 200x; (A) Crypts on initial plating for goal density of 25 crypts/well (B)
Representative enterosphere at 1 day; (C) Enterosphere budding at 3 days; and D)
Representative enteroid at 7 days, note crypt buds (arrowhead ∧) are roughly the same size
as initially plated crypts.
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FIG. 2. Quantitative behavior of crypts in culture
(A) Enterosphere efficiency. Percent of crypts surviving as enteroids at 24 hr, measured by:
region of small intestine and age of animal. Symbols represent p < 0.05 for: ∏ = between
proximal and distal, † = proximal 20 < 14 wk, € = distal 20 < 4, 8, 14 wks. (B) Enteroid
efficiency. Percent of crypts yielding enteroids at 7 days, measured by: region of small
intestine and age of animal. Symbols represent p < 0.05 for: ∏ = between proximal and
distal, * = proximal 8 wk > 14, 20wk, # = distal 8wk > 4, 14, 20wk (C) Enterosphere
progression. Percent of enterospheres at 24 hr progressing to enteroids at 7 days, measured
by: region of small intestine and age of animal. Symbols represent p < 0.05 for: § =
proximal 8 > 4, 14wk, ° = distal 8 > 14wk.
Data are shown as means ± SE for biologic n = 4, 6, 4, and 6 at ages 4, 8, 12, and 20 wk
respectively. For simplicity of graphical visualization the middle region has been omitted
from figs 2A-C.
Fuller et al. Page 10













FIG. 3. Crypt buds by region
Number of new crypt domains (buds) per enteroid at 7 days measured by: region of small
intestine (proximal, middle, or distal) pooled for all ages. All data are represented as means
± SE with biologic n = 20. (** p < 0.001)
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FIG. 4. Continued crypt expansion
Enteroid efficiency of the proximal and distal intestine after passage 1 (passaged at day 7,
quantified at day 14) and passage 2 (passaged at day 14, quantified at day 21). All data are
shown as means ± SE biologic n=3.
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FIG. 5. Crypt expansion by region
Fold expansion of crypts at 7 days measured by region (proximal or distal) and pooled for
all ages (black and gray bars respectively) biologic n = 20 for all regions. (**p<0.001) Fold
expansion for the single best age (8wks) is represented by the open bars, n = 6. All data are
represented as means ± SE
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